Lakefront Biotherapeutics | GLPG - Stock


Lakefront Biotherapeutics reported EUR17.69M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
argenx SE USD 473.53M 132.91M Dec/2025
AstraZeneca USD 6.93B 362M Jun/2026
Biogen USD 2.38B 435.3M Jun/2026
Genmab DKK 13M 1000K Jun/2025
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
GRIFOLS EUR 3.49B 34M Jun/2026
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
Incyte USD 112.54M 3.08M Jun/2026
Merck EUR 4.78B 220M Mar/2026
Neurocrine Biosciences USD 104.2M 39.7M Jun/2026
Novartis USD 6.22B 66M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026
UCB EUR 1.31B 173M Dec/2024
Vertex Pharmaceuticals USD 1.77B 1.6M Jun/2026